Recombinant Escherichia coli O17:K52:H18 GMP synthase [glutamine-hydrolyzing] (guaA)

Shipped with Ice Packs
In Stock

Description

Overview of GMP Synthase (guaA)

GMP synthase, encoded by the guaA gene, is a critical enzyme in purine metabolism, catalyzing the conversion of xanthosine monophosphate (XMP) to guanosine monophosphate (GMP) using L-glutamine and ATP. Its role is central to nucleotide biosynthesis in E. coli, enabling the production of guanine nucleotides essential for DNA/RNA synthesis and cellular signaling .

The recombinant form of this enzyme, derived from E. coli O17:K52:H18, retains the native catalytic properties but is engineered for enhanced expression and stability in heterologous systems. This strain-specific serotype (O17:K52:H18) belongs to the Enterobacteriaceae family, with serotyping based on O (lipopolysaccharide) and H (flagellar) antigens .

Biochemical Properties

Table 1: Key Biochemical Characteristics of GMP Synthase (guaA)

PropertyValue/DescriptionReference
Molecular Weight58,604 Da (525 amino acids)
Catalytic ActivityXMP + L-glutamine + ATP → GMP + L-glutamate + AMP + PPi
Optimal ConditionsMg²⁺/ATP-dependent; pH 7.5–8.5
StabilityRequires dithioerythritol as preservative

The enzyme operates via a glutamine amidotransferase mechanism, with a conserved aspartate residue (D72) critical for catalysis . Its activity is modulated by ATP availability and feedback inhibition by GMP .

Recombinant Production

Recombinant GMP synthase is typically overexpressed using E. coli strains like MP347/pPLA66, which employs the lambda phage PL promoter and trpL SD sequence for high transcription efficiency . This system achieved a 370-fold increase in activity compared to wild-type strains, with the enzyme constituting ~34% of total cellular protein .

Key Optimization Strategies:

  • Promoter Engineering: Lambda phage PL promoter for constitutive expression .

  • Fermentation Media: Corn steep liquor-based media for cost-effective scale-up .

  • Post-Translational Processing: No reported modifications; native folding is sufficient .

Applications

  • Industrial Biotechnology: Used in coupled reactions with Corynebacterium ammoniagenes to produce GMP from XMP, achieving 85% molar conversion without exogenous ATP .

  • Metabolic Engineering: A target for manipulating purine metabolism in bioengineered E. coli strains .

Research Insights

Recent studies highlight guaA as a node in metabolic trade-offs. For example, overexpression of GMP synthase can alter cellular ATP pools, influencing growth rates and stress responses . Additionally, phase variation events (e.g., c-di-GMP signaling) in E. coli strains like IHE3034/R S218 link metabolic phenotypes (citrate utilization) to morphotypic traits (filamentation), underscoring the enzyme’s role in balancing energy metabolism .

Q&A

What is GMP synthase (guaA) and what is its role in nucleotide metabolism?

GMP synthase [glutamine-hydrolyzing], encoded by the guaA gene in E. coli, catalyzes the ATP-dependent conversion of xanthosine 5'-monophosphate (XMP) to guanosine 5'-monophosphate (GMP) in the de novo purine biosynthesis pathway. This enzyme plays a critical role in the final step of GMP biosynthesis, utilizing glutamine as an amino group donor and ATP as an energy source.

The reaction proceeds through amidation of XMP at the C-2 position, resulting in the formation of GMP. The enzyme constitutes an essential metabolic component for nucleic acid synthesis in rapidly dividing bacterial cells. In recombinant expression systems, the activity of this enzyme can be increased approximately 370-fold compared to wild-type strains, representing up to 34% of the total cellular protein under optimized conditions .

What expression systems are most effective for recombinant guaA production?

Based on empirical evidence, high-level expression of guaA can be achieved using the PL promoter of lambda phage coupled with the Shine-Dalgarno (SD) sequence of trpL from E. coli positioned at an appropriate distance upstream of the guaA gene. This configuration has demonstrated superior performance in maximizing expression levels.

A particularly effective system incorporates:

  • PL promoter of lambda phage

  • SD sequence from E. coli trpL

  • ATG start codon positioned optimally upstream of the guaA gene

  • Conservation of the C-terminal region of the guaB gene, which encodes IMP dehydrogenase

  • A short peptide consisting of 14 amino acids coded upstream of guaA

This combination has been shown to increase enzyme activity approximately 370-fold compared to standard strains like MM294, with the recombinant enzyme constituting approximately 34% of total cellular protein .

How can I verify the successful expression of recombinant guaA?

Successful expression of recombinant guaA can be verified through multiple complementary approaches:

  • SDS-PAGE Analysis: The expected molecular weight of GMP synthase is approximately 58-60 kDa. When properly expressed, a prominent band should be visible at this position on SDS-PAGE gels. Comparison with non-induced controls can confirm the identity of the target protein band .

  • Enzymatic Activity Assay: A functional assay measuring the conversion of XMP to GMP offers the most definitive verification. This can be quantified using HPLC analysis of reaction products, with ATP consumption or AMP formation serving as secondary indicators of enzyme activity .

  • Western Blot Analysis: Using antibodies specific to GMP synthase or to an incorporated tag (such as His6), Western blotting provides high-specificity confirmation of expression.

  • Mass Spectrometry: For definitive identification, tryptic digestion of the excised protein band followed by mass spectrometry analysis can confirm the protein identity through peptide mass fingerprinting.

What media formulations optimize recombinant guaA expression in E. coli?

Media composition significantly impacts both the quantity and quality (solubility) of recombinant proteins including guaA. Rather than relying on standard formulations, empirical screening of multiple media options is recommended for each specific construct.

Recommended screening approach:

  • Test a panel of media formulations with varying nutrient compositions

  • Evaluate both biomass (OD600) and specific protein yield

  • Assess protein solubility in each condition

For guaA expression specifically, media rich in yeast-derived components such as corn steep liquor have shown promising results. In one study, a medium containing primarily corn steep liquor supported high XMP aminase activity in E. coli MP347/pPLA66 .

The optimization goal should be to produce the highest amount of functional product per unit volume per unit time, not merely the highest total protein. For this reason, conditions that produce moderate expression levels with higher solubility may be preferable to conditions that drive very high expression but predominantly as inclusion bodies .

What strategies can overcome inhibitory feedback regulation of guaA expression?

Feedback inhibition by pathway end products represents a significant challenge in metabolic engineering. For guaA and related systems, several approaches have proven effective:

  • Riboswitch Deletion/Modification: The deletion of FMN riboswitch elements can significantly increase transcript levels of target genes. A similar approach may be applicable to guaA, as demonstrated with ribB in related pathways where deletion of 223 bp of nucleotides upstream of the RBS sequence increased expression .

  • Promoter Engineering: Replacing native promoters with strong, inducible promoters like PL can bypass natural regulatory mechanisms.

  • Co-expression of Multiple Pathway Enzymes: Coordinated overexpression of multiple enzymes in a pathway can overcome rate-limiting steps and prevent the accumulation of inhibitory intermediates. In analogous systems, co-expression of five key genes plus zwf (glucose-6-phosphate dehydrogenase) resulted in significant production increases .

How can the XMP to GMP conversion be optimized in cell-based systems?

Optimizing the enzymatic conversion of XMP to GMP requires addressing several key parameters:

Reaction conditions for optimal conversion:

  • pH: Maintain between 7.2-7.8

  • Temperature: 30-37°C (typically 30°C provides better enzyme stability)

  • Cofactor supplementation: ATP, Mg2+, Glutamine

  • Permeabilization agents: Addition of surfactants like Nymeen S-215 and xylene can make cell membranes permeable to nucleotides, enhancing substrate accessibility

In a coupled biocatalyst system using E. coli MP347/pPLA66 and Corynebacterium ammoniagenes, high conversion rates (85% molar yield) were achieved without external ATP addition. This approach utilized 600 ml of XMP-fermentation broth from C. ammoniagenes KY13203 and 30 ml of cultured broth of engineered E. coli, resulting in accumulation of 70 mg/ml (131 mM) of GMP·Na2·7H2O from 83 mg/ml (155 mM) of XMP·Na3·7H2O .

The success of this system without external ATP addition suggests that ATP was regenerated from AMP by C. ammoniagenes and supplied to E. coli cells, establishing an effective coupling reaction between the two strains .

How can metabolic engineering enhance substrate availability for guaA?

Metabolic engineering approaches to enhance substrate availability for GMP synthase include:

  • Overexpression of zwf gene: The zwf gene encodes glucose-6-phosphate dehydrogenase, which increases NADPH production and enhances glucose utilization. In similar recombinant systems, zwf overexpression resulted in a 74.66% increase in product formation and a 22.01% increase in cell density (OD600) .

  • Pathway balancing: Coordinated expression of upstream enzymes (like those encoded by ribA, ribB, ribC, ribD, and ribE genes in riboflavin production systems) can increase pathway flux and prevent bottlenecks in substrate availability.

  • Deletion of competing pathways: Removing genes involved in competing metabolic branches can redirect carbon flux toward the desired pathway.

Table 1: Impact of zwf overexpression on recombinant strain performance (adapted from similar systems)

StrainDescriptionOD600Product Titer (mg/L)Improvement (%)
R1Base strain with key pathway genes7.18 ± 0.36182.65 ± 9.04-
R2R1 + zwf overexpression8.76 ± 0.12319.01 ± 20.6574.66

What analytical methods provide the most accurate quantification of guaA activity?

Multiple analytical approaches can be used for accurate quantification of GMP synthase activity:

  • HPLC Analysis: High-performance liquid chromatography provides the most definitive measurement of XMP conversion to GMP. Typical conditions include:

    • C18 reverse-phase column

    • Mobile phase: typically phosphate buffer with methanol gradient

    • UV detection at 254-260 nm

    • Standard curves using authentic GMP standards

  • Coupled Enzyme Assays:

    • ATP consumption can be monitored through coupled enzyme systems (pyruvate kinase and lactate dehydrogenase)

    • NADH oxidation measured at 340 nm correlates with ATP utilization

  • Isothermal Titration Calorimetry (ITC): For kinetic studies, ITC can measure the heat released during the enzymatic reaction, providing real-time reaction rates.

For expression verification, SDS-PAGE analysis should show a band corresponding to the expected molecular weight of the target protein (approximately 58-60 kDa for GMP synthase) .

How can ATP regeneration systems improve the efficiency of guaA-catalyzed reactions?

ATP regeneration is critical for sustained GMP synthase activity in vitro and in whole-cell biotransformations. Several strategies have proven effective:

  • Coupled Cellular Systems: Using two different bacterial strains in a coupled system can establish effective ATP regeneration. For example, when C. ammoniagenes and recombinant E. coli cells are used together, ATP regeneration occurs naturally - ATP is regenerated from AMP by C. ammoniagenes cells and supplied to E. coli cells carrying the guaA gene .

  • Enzymatic Regeneration Systems:

    • Pyruvate kinase + phosphoenolpyruvate

    • Acetate kinase + acetyl phosphate

    • Creatine kinase + creatine phosphate

  • Whole-cell Permeabilization: Addition of surfactants like Nymeen S-215 and xylene can make cell membranes permeable to nucleotides while maintaining cellular ATP regeneration mechanisms .

What are common pitfalls in recombinant guaA expression and how can they be addressed?

Several challenges commonly arise during recombinant GMP synthase expression:

  • Inclusion Body Formation:

    • Problem: High expression levels often lead to protein aggregation

    • Solution: Lower induction temperature (16-25°C), co-expression with chaperones (GroEL/ES, DnaK/J), or fusion with solubility tags (MBP, SUMO)

  • Low Specific Activity:

    • Problem: Expressed protein shows poor catalytic performance

    • Solution: Optimize buffer conditions (pH, ionic strength), ensure proper cofactor availability, verify protein folding through circular dichroism

  • Plasmid Instability:

    • Problem: Loss of expression plasmid during cultivation

    • Solution: Optimize antibiotic concentration, use lower copy number vectors, or integrate the gene into the chromosome

  • Metabolic Burden:

    • Problem: Overexpression impairs cell growth

    • Solution: Use tunable promoters, optimize induction timing, or employ auto-induction media

The employment of a systematic medium screening approach can identify formulations that minimize these issues for specific constructs .

How does the choice of E. coli strain affect guaA expression and activity?

The host strain significantly impacts recombinant protein expression outcomes. Key considerations include:

  • Protease Deficiency: Strains like BL21(DE3) lack lon and ompT proteases, reducing degradation of recombinant proteins. For guaA expression, BL21 derivatives have shown good results, with MP347/pPLA66 demonstrating particularly high activity .

  • Codon Usage: For genes with rare codons, strains supplemented with rare tRNA genes (like Rosetta) may improve expression levels.

  • Metabolic Background: Strains with relevant pathway modifications can improve precursor availability. For guaA specifically, strains with enhanced purine pathway flux may increase productivity.

  • Genetic Modifications: Targeted modifications, such as riboswitch deletions as demonstrated with FMN riboswitch deletion in analogous systems, can significantly improve gene expression and product yields .

In comparative studies of analogous systems, strain engineering involving both gene overexpression and regulatory element deletion resulted in production increases from 182.65 mg/L in base strains to 611.22 mg/L in optimized strains, with further improvements to 1,574.60 mg/L through fed-batch fermentation approaches .

What emerging technologies might enhance guaA expression and application?

Several cutting-edge approaches show promise for improving recombinant GMP synthase production and application:

These approaches represent the frontier of recombinant protein production technology and may address persistent challenges in guaA expression and application.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.